Fig. 6From: mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagyWestern blot analyses of the expression levels of bax, cleaved caspase 3, Parp, LC3 and MDR1 proteins in cells after treatments. *P < 0.05, vs the bax protein expression of controlled group, #P < 0.05, vs the cleaved caspase 3 protein expression of controlled group, ▲P < 0.05, vs the cleaved parp expression of controlled group, ▼P < 0.05, vs the LC3 II/LC I expression of controlled group, ◆P < 0.05, vs the MDR1 expression of controlled group, data were presented as mean ± SD (n = 3)Back to article page